Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis
about
Genome plasticity of BCG and impact on vaccine efficacyA second-generation anti TB vaccine is long overdueMalaria infections do not compromise vaccine-induced immunity against tuberculosis in miceGenome-wide screen for Mycobacterium tuberculosis genes that regulate host immunityOral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against TuberculosisEvolution of M. bovis BCG Vaccine: Is Niacin Production Still a Valid Biomarker?Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West AfricaThe multifunctional PE_PGRS11 protein from Mycobacterium tuberculosis plays a role in regulating resistance to oxidative stressSrc homology 3-interacting domain of Rv1917c of Mycobacterium tuberculosis induces selective maturation of human dendritic cells by regulating PI3K-MAPK-NF-kappaB signaling and drives Th2 immune responsesThe HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunityPreclinical evidence for implementing a prime-boost vaccine strategy for tuberculosisRecombinant Mycobacterium bovis BCG as an HIV vaccine vector.Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses.Oral Administration of Heat-Killed Mycobacterium manresensis Delays Progression toward Active Tuberculosis in C3HeB/FeJ Mice.Persistence of the immune response induced by BCG vaccination.Effect of attenuation of Treg during BCG immunization on anti-mycobacterial Th1 responses and protection against Mycobacterium tuberculosis.Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.The co-operonic PE25/PPE41 protein complex of Mycobacterium tuberculosis elicits increased humoral and cell mediated immune response.Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen doseSafety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85AImmunological memory transferred with CD4 T cells specific for tuberculosis antigens Ag85B-TB10.4: persisting antigen enhances protection.Protective efficacy of BCG overexpressing an L,D-transpeptidase against M. tuberculosis infection.Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens.Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis.Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG PasteurImmunogenicity of a recombinant Mycobacterium smegmatis vaccine expressing the fusion protein CMX in cattle from Goiás State, Brazil.Effectiveness of BCG vaccination to aged mice.Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosisRecombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge.Host response to nontuberculous mycobacterial infections of current clinical importance.Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosisEffect of non-tuberculous Mycobacteria on host biomarkers potentially relevant for tuberculosis management.Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis.Bacillus Calmette-Guérin vaccination and infant mortality.Molecular confirmation of Bacillus Calmette Guerin vaccine related adverse events among Saudi Arabian children.Distribution of environmental mycobacteria in Karonga District, northern Malawi.Mycobacterium bovis BCG vaccines exhibit defects in alanine and serine catabolism.
P2860
Q24674276-BAFCE559-B25D-476D-B863-E30FD33EEFF9Q24800887-A6158023-6736-48E0-9503-CFD6F132BF20Q27311568-844C0D8C-6D6C-48BF-BE1A-91C265514A64Q27313489-FAD00AD0-9751-40ED-BD0C-168F6884E6FBQ27313927-CD0643E0-346D-4806-8BDF-6E5E3A17FF09Q28083050-7C66B6BA-74F6-4BDD-ABC2-68FC3B74C029Q28473318-1FAE9C91-A35B-4AC4-BEB9-5DCF1E6F0993Q28486603-4BC4CC4F-35D6-470A-91CE-C9F755BE840AQ28487315-8AA52675-C5BA-4BBE-B5CF-E4A3E8375C6EQ28727776-ADA1B769-5597-48A6-86B5-29DD42ABEE45Q28730427-71279E33-F994-40FB-977D-267B6BBBA406Q30387447-2A2B66AF-882D-4325-9A16-34280697F058Q30408875-ACB51AB9-DBD6-47A5-BCFB-534B7B320FEAQ31037455-FBFA6351-501C-48B2-91FE-6BDFE764B9C8Q33316559-24F53012-FA67-4426-A356-678A2BC035F0Q33355965-E12CF269-B651-4A9B-B8BC-B38F0F6050E5Q33369563-A6E6C772-8A4E-4B3E-BB3C-73F4671DA1DBQ33381629-D7B6731E-7B83-412C-87F6-0035EA5C0311Q33468422-CC0D48F2-3296-4746-831A-AF367B84CE38Q33468451-D9F72413-1624-4A7E-996F-58953059A3B0Q33518560-501D76DE-612F-4278-BE55-2BF0B616318EQ33737428-AD3A926D-7B61-4C9F-8D1B-B6AF0ADE4CD1Q33769431-892067F3-7A50-443A-880B-95CE06EC2DBDQ33788201-3897BBCB-0A8A-460D-B72B-FCC03EE8EAF6Q33791961-E9013A81-3D5A-49AB-91E7-DFFD8BD3DAC3Q33796833-DE204EC8-4D81-4158-A0C2-CE3E1B245B9AQ33877920-33C11EF9-EEF5-44D3-AA83-D2E58A31B1E1Q34085461-440E7494-28EA-440E-9A01-DE6AC7505A61Q34116842-AB8E84CE-18B4-4C82-A69A-82ACD9CBE9DCQ34122078-3C1ECF4D-EF4E-4771-B57B-31E4D93BD4A5Q34145933-19D1746B-AA12-4EE5-B5CF-BC73050CF45EQ34298306-C4246B0F-D902-45F9-B005-AD0B13F43358Q34306108-B782D24B-CF6C-4637-9643-75887AE38776Q34351278-255EDA80-DD70-49F5-9217-35CC03E1D5F8Q34361636-969154C4-4DE7-41D0-892A-F0B07E326298Q34491796-F702B86A-A4C4-41E4-9472-18D3BCBA7CCBQ34512747-F07DDBD9-6F52-4BB9-9448-59C2A7779B5CQ34542530-7041FCA0-747D-4F3C-B382-47F52375A5E6Q34570558-5130141A-92EB-4D44-A46F-B7D012A91513Q34581513-4F03B9E7-3B72-4DDA-82B2-F590FEFFF085
P2860
Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Failure of the Mycobacterium b ...... ctive immunity to tuberculosis
@ast
Failure of the Mycobacterium b ...... ctive immunity to tuberculosis
@en
Failure of the Mycobacterium b ...... ctive immunity to tuberculosis
@nl
type
label
Failure of the Mycobacterium b ...... ctive immunity to tuberculosis
@ast
Failure of the Mycobacterium b ...... ctive immunity to tuberculosis
@en
Failure of the Mycobacterium b ...... ctive immunity to tuberculosis
@nl
prefLabel
Failure of the Mycobacterium b ...... ctive immunity to tuberculosis
@ast
Failure of the Mycobacterium b ...... ctive immunity to tuberculosis
@en
Failure of the Mycobacterium b ...... ctive immunity to tuberculosis
@nl
P2093
P2860
P3181
P1476
Failure of the Mycobacterium b ...... ctive immunity to tuberculosis
@en
P2093
Anja Weinreich Olsen
Ben Chilima
Joana Feino Cunha
Lise Brandt
Penny Hirsch
P2860
P3181
P356
10.1128/IAI.70.2.672-678.2002
P407
P577
2002-02-01T00:00:00Z